Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Anagrelide price in mercury drug philippines?Can stretching enhance lipitor's therapeutic benefits?Asmanex organon patent?Triferic avnu side effects?Why is hetlioz so expensive?
See the DrugPatentWatch profile for Parnate
Parnate is the brand name for tranylcypromine. NDA 012342’s approval date is not provided in the information available to me here, so I can’t state the exact FDA approval date for that specific NDA.
To get the precise approval date, the most reliable place is the FDA’s drug approval databases (such as Drugs@FDA) for NDA 012342, or a referenced patent/drug database entry that lists the NDA approval date. If you want, share the FDA page details you’re seeing (or a link/screenshot), and I can help interpret what it means for “Parnate” versus other NDA entries.
Sometimes users look up “Parnate” and find multiple FDA records (for example, different NDA numbers, supplement applications, or labeling/route changes). Confirming that NDA 012342 specifically maps to tranylcypromine/Parnate is key before relying on any listed date.
If you paste the text from the Drugs@FDA entry for NDA 012342 (especially the “Approval Date” field) or link to the page, I’ll extract the approval date cleanly and report it back.
Other Questions About Parnate :